Acta Ophthalmologica | 2019
Dexamethasone for unresponsive diabetic macular oedema: optical coherence tomography biomarkers
Abstract
To analyse the effects of intravitreal dexamethasone implant (DEX) in patients with diabetic macular oedema (DME) unresponsive to ranibizumab treatment, in relation to the inflammatory optical coherence tomography (OCT) retinal features, subfoveal neuroretinal detachment (SND) and hyperreflective retinal spots (HRS).